Sanofi announces UK appointments

1 February 2017

French pharma major Sanofi (Euronext: SAN) today announces the appointment of Hugo Fry as general manager for the UK and general manager Sanofi Pasteur for the UK & Ireland, and Dr Hubert Bland as UK medical chair and medical head of diabetes and cardiovascular for the UK & Ireland.

Hugo Fry has over 20 years of experience in the pharmaceutical industry and has held various global and regional management, commercial and strategic roles. Prior to assuming this role, he was the chief marketing officer for Sanofi Pasteur MSD (SPMSD), leading the commercial effort for the European Vaccine Joint Venture. He brings a wealth of experience in commercial leadership, and delivering growth and driving performance in healthcare.

Dr Bland joins Sanofi from TMC Pharma, where he held the role of vice president of medical since 2013. Prior to this, he held medical leadership positions at Pfizer, Boehringer-Ingelheim, Linde and the University of Surrey's Clinical Research Centre.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK